SCHEMBL3383307

SCHEMBL3383307

Cc1ccc(NC(=O)Nc2cccc(-c3ccc4c(C(=O)O)n[nH]c4c3)c2)c(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.49
MAP2K7 O14733 1/20 0.48
FLT3 P36888 8/20 0.46
MAP4K1 Q92918 2/20 0.46
FLT1 P17948 6/20 0.45
FLT4 P35916 6/20 0.45
ROCK2 O75116 5/20 0.45
AURKB Q96GD4 5/20 0.45
KIT P10721 5/20 0.45
CSF1R P07333 5/20 0.45
AURKA O14965 4/20 0.45
PLK4 O00444 3/20 0.45
NTRK2 Q16620 3/20 0.45
MARK2 Q7KZI7 3/20 0.45
LCK P06239 3/20 0.45
RET P07949 3/20 0.45
AXL P30530 3/20 0.45
FRK P42685 3/20 0.45
RPS6KA3 P51812 3/20 0.45
RPS6KB1 P23443 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3386700 0.90 KDR (0.48) KDRMAP2K7FLT3MAP4K1FLT1
SCHEMBL3387734 0.88 FLT3 (0.47) KDRMAP2K7FLT3MAP4K1FLT1
SCHEMBL3386648 0.81 KDR (0.52) KDRFLT3FLT1FLT4ROCK2
SCHEMBL3387499 0.80 CNR1 (0.56) KDRFLT3FLT1FLT4ROCK2
SCHEMBL3384615 0.75 SMN1; SMN2 (0.53) MAP2K7FLT3MAP4K1ROCK2ROCK1
SCHEMBL1330072 0.74 KDR (0.75) KDRMAP2K7FLT3FLT1FLT4
SCHEMBL3385660 0.74 KDR (0.78) KDRFLT3FLT1FLT4ROCK2
SCHEMBL12090187 0.73 MAPK1 (0.50) FLT3MAP4K1ITK
SCHEMBL13336967 0.72 KDR (0.61) KDRFLT3MAP4K1FLT1FLT4
SCHEMBL3387051 0.72 KDR (0.47) KDRAURKAGSK3BAAK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed